Literature DB >> 19446264

Differences in peptic ulcer between the East and the West.

Rupert W Leong1.   

Abstract

PUD affects both the East and the West. The magnitude of the problem, however, varies within these regions. The study of peptic ulcer epidemiology is impeded by the paucity of general population-based data, invasiveness of diagnostic tests, and variable access to testing facilities. As such, direct comparisons of PUD epidemiology between the East and the West are difficult. The prevalence rates of H pylori are highly variable and depend greatly on the local sanitation conditions. The use of NSAIDs and aspirin is ubiquitous and increasing especially for the antiplatelet activity of aspirin in the prophylaxis of cardiovascular events. There is evidence that pharmacogenetics play a role in susceptibility to the ulcerogenic properties of NSAIDs. The prevalence of PUD parallels the risk factors, but emerging in both the East and the West is idiopathic PUD, now a substantial proportion of ulcers in areas of declining H pylori infection. Genetic polymorphisms affect the efficacy of treatment using PPIs. Local H pylori resistance rates also influence the eradication success rates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19446264     DOI: 10.1016/j.gtc.2009.03.010

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  12 in total

Review 1.  Efficacy of ilaprazole in the treatment of duodenal ulcers: a meta-analysis.

Authors:  Xi-Qing Ji; Jun-Feng Du; Gang Chen; Guang Chen; Bo Yu
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 2.  Risk assessment and aspirin use in Asian and Western populations.

Authors:  Runlin Gao; Xiaoying Li
Journal:  Vasc Health Risk Manag       Date:  2010-10-21

Review 3.  Different Pathophysiology of Gastritis in East and West? A Western Perspective.

Authors:  Hans-Peter Wirth; Manqiao Yang
Journal:  Inflamm Intest Dis       Date:  2016-05-14

4.  The Role of Helicobacter pylori and NSAIDs in the Pathogenesis of Uncomplicated Duodenal Ulcer.

Authors:  Ayhan Hilmi Cekin; Muharrem Taskoparan; Adil Duman; Cem Sezer; Yesim Cekin; Basak Oguz Yolcular; Hasan Can; Fatma Seher Pehlivan; Mine Cayirci
Journal:  Gastroenterol Res Pract       Date:  2012-09-25       Impact factor: 2.260

5.  Are Helicobacter pylori and other Helicobacter species infection associated with human biliary lithiasis? A meta-analysis.

Authors:  Di Zhou; Yong Zhang; Wei Gong; Sayid Omar Mohamed; Henry Ogbomo; Xuefeng Wang; Yingbin Liu; Zhiwei Quan
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

6.  Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects.

Authors:  Yuuichi Sakurai; Akira Nishimura; Gale Kennedy; Mark Hibberd; Richard Jenkins; Hiroyuki Okamoto; Tomoki Yoneyama; Helen Jenkins; Kiyoshi Ashida; Shin Irie; Jörg Täubel
Journal:  Clin Transl Gastroenterol       Date:  2015-06-25       Impact factor: 4.488

Review 7.  Ethnic Differences in Oral Antithrombotic Therapy.

Authors:  Haechan Cho; Jeehoon Kang; Hyo Soo Kim; Kyung Woo Park
Journal:  Korean Circ J       Date:  2020-08       Impact factor: 3.243

8.  Is Helicobacter pylori Infection the Primary Cause of Duodenal Ulceration or a Secondary Factor? A Review of the Evidence.

Authors:  Vikram Kate; N Ananthakrishnan; Frank I Tovey
Journal:  Gastroenterol Res Pract       Date:  2013-03-27       Impact factor: 2.260

9.  High Recurrence Rate of Idiopathic Peptic Ulcers in Long-Term Follow-up.

Authors:  Hyuk Yoon; Sang Gyun Kim; Hyun Chae Jung; In Sung Song
Journal:  Gut Liver       Date:  2013-03-14       Impact factor: 4.519

10.  Cost Effectiveness Associated with Helicobacter pylori Screening and Eradication in Patients Taking Nonsteroidal Anti-Inflammatory Drugs and/or Aspirin.

Authors:  Hyun Jin Song; Jin-Won Kwon; Nayoung Kim; Young Soo Park
Journal:  Gut Liver       Date:  2013-03-14       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.